Search results
Results from the WOW.Com Content Network
Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. [1] It most frequently starts from one of the adrenal glands but can also develop in the head, neck, chest, abdomen, or spine. [1]
Treatment using these targets can supplement or replace some of the intensive chemotherapy that is used for neuroblastoma. These molecular targets of this disease include GD2 , ALK , and CD133 . GD2 is a target of immunotherapy , and is the most fully developed of these treatment methods, but is also associated with toxicities. [ 1 ]
The Neuroblastoma Alliance UK helps families access and fundraise for their child's treatment abroad. Various new treatments for neuroblastoma are being trialled in the UK, but if children do not meet the criteria for a trial, or need treatment that is only available abroad, families have to pay for their child's treatment abroad.
Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute–designated Comprehensive Cancer Centers. [3] [4] Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
The group, with more than 7,500 experts worldwide, has nearly 100 active clinical-translational trials open at any given time. These trials include treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. [1] [2] [3] The center is usually called Roswell Park in short.
MD Anderson Services Corporation [102] (formerly MD Anderson Cancer Center Outreach Corporation [103]) was established in 1989 as a not-for-profit corporation to enhance revenues of The University of Texas MD Anderson Cancer Center by establishing joint ventures in selected markets, providing additional referrals to the institution, contracting ...
In 2019, JTCC received approval from the National Cancer Institute (NCI) as a member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center. [6] The partnership focuses on advancing research and treatment in breast cancer, cancer prevention and control, experimental therapeutics and molecular oncology.